ArticleBreast cancer research and treatment2012

SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).

Chunyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.